343 related articles for article (PubMed ID: 31390228)
21. Palmitoylethanolamide Promotes a Proresolving Macrophage Phenotype and Attenuates Atherosclerotic Plaque Formation.
Rinne P; Guillamat-Prats R; Rami M; Bindila L; Ring L; Lyytikäinen LP; Raitoharju E; Oksala N; Lehtimäki T; Weber C; van der Vorst EPC; Steffens S
Arterioscler Thromb Vasc Biol; 2018 Nov; 38(11):2562-2575. PubMed ID: 30354245
[TBL] [Abstract][Full Text] [Related]
22. Elevated expression of macrophage MERTK exhibits profibrotic effects and results in defective regulation of efferocytosis function in pulmonary fibrosis.
She Y; Xu X; Yu Q; Yang X; He J; Tang XX
Respir Res; 2023 Apr; 24(1):118. PubMed ID: 37120511
[TBL] [Abstract][Full Text] [Related]
23. Differential activation of mitogen-activated protein kinases in smooth muscle cells by angiotensin II: involvement of p22phox and reactive oxygen species.
Viedt C; Soto U; Krieger-Brauer HI; Fei J; Elsing C; Kübler W; Kreuzer J
Arterioscler Thromb Vasc Biol; 2000 Apr; 20(4):940-8. PubMed ID: 10764657
[TBL] [Abstract][Full Text] [Related]
24. MERTK tyrosine kinase receptor together with TIM4 phosphatidylserine receptor mediates distinct signal transduction pathways for efferocytosis and cell proliferation.
Nishi C; Yanagihashi Y; Segawa K; Nagata S
J Biol Chem; 2019 May; 294(18):7221-7230. PubMed ID: 30846565
[TBL] [Abstract][Full Text] [Related]
25. MerTK cleavage limits proresolving mediator biosynthesis and exacerbates tissue inflammation.
Cai B; Thorp EB; Doran AC; Subramanian M; Sansbury BE; Lin CS; Spite M; Fredman G; Tabas I
Proc Natl Acad Sci U S A; 2016 Jun; 113(23):6526-31. PubMed ID: 27199481
[TBL] [Abstract][Full Text] [Related]
26. Angiotensin-(1-7) modulates renal vascular resistance through inhibition of p38 mitogen-activated protein kinase in apolipoprotein E-deficient mice.
Potthoff SA; Fähling M; Clasen T; Mende S; Ishak B; Suvorava T; Stamer S; Thieme M; Sivritas SH; Kojda G; Patzak A; Rump LC; Stegbauer J
Hypertension; 2014 Feb; 63(2):265-72. PubMed ID: 24191281
[TBL] [Abstract][Full Text] [Related]
27. Antioxidants inhibit JNK and p38 MAPK activation but not ERK 1/2 activation by angiotensin II in rat aortic smooth muscle cells.
Kyaw M; Yoshizumi M; Tsuchiya K; Kirima K; Tamaki T
Hypertens Res; 2001 May; 24(3):251-61. PubMed ID: 11409648
[TBL] [Abstract][Full Text] [Related]
28. Enhanced efferocytosis of apoptotic cardiomyocytes through myeloid-epithelial-reproductive tyrosine kinase links acute inflammation resolution to cardiac repair after infarction.
Wan E; Yeap XY; Dehn S; Terry R; Novak M; Zhang S; Iwata S; Han X; Homma S; Drosatos K; Lomasney J; Engman DM; Miller SD; Vaughan DE; Morrow JP; Kishore R; Thorp EB
Circ Res; 2013 Sep; 113(8):1004-12. PubMed ID: 23836795
[TBL] [Abstract][Full Text] [Related]
29. BMS794833 inhibits macrophage efferocytosis by directly binding to MERTK and inhibiting its activity.
Bae SH; Kim JH; Park TH; Lee K; Lee BI; Jang H
Exp Mol Med; 2022 Sep; 54(9):1450-1460. PubMed ID: 36056187
[TBL] [Abstract][Full Text] [Related]
30. Targeted delivery of MerTK protein via cell membrane engineered nanoparticle enhances efferocytosis and attenuates atherosclerosis in diabetic ApoE
Qiu S; Liu J; Chen J; Li Y; Bu T; Li Z; Zhang L; Sun W; Zhou T; Hu W; Yang G; Yuan L; Duan Y; Xing C
J Nanobiotechnology; 2024 Apr; 22(1):178. PubMed ID: 38614985
[TBL] [Abstract][Full Text] [Related]
31. MerTK Cleavage on Resident Cardiac Macrophages Compromises Repair After Myocardial Ischemia Reperfusion Injury.
DeBerge M; Yeap XY; Dehn S; Zhang S; Grigoryeva L; Misener S; Procissi D; Zhou X; Lee DC; Muller WA; Luo X; Rothlin C; Tabas I; Thorp EB
Circ Res; 2017 Sep; 121(8):930-940. PubMed ID: 28851810
[TBL] [Abstract][Full Text] [Related]
32. The Important Role of Phosphatidylserine, ADAM17, TNF-Alpha, and Soluble MER on Efferocytosis Activity in Central Obesity.
Purnama CA; Meiliana A; Barliana MI; Lestari K; Wijaya A
J Obes; 2024; 2024():1424404. PubMed ID: 38550672
[TBL] [Abstract][Full Text] [Related]
33. A+T rich interaction domain protein 3a (Arid3a) impairs Mertk-mediated efferocytosis in cholestasis.
Chen R; Huang B; Lian M; Wei Y; Miao Q; Liang J; Ou Y; Liang X; Zhang H; Li Y; Xiao X; Wang Q; You Z; Chai J; Gershwin ME; Tang R; Ma X
J Hepatol; 2023 Dec; 79(6):1478-1490. PubMed ID: 37659731
[TBL] [Abstract][Full Text] [Related]
34. ERK and p38 MAPK, but not NF-kappaB, are critically involved in reactive oxygen species-mediated induction of IL-6 by angiotensin II in cardiac fibroblasts.
Sano M; Fukuda K; Sato T; Kawaguchi H; Suematsu M; Matsuda S; Koyasu S; Matsui H; Yamauchi-Takihara K; Harada M; Saito Y; Ogawa S
Circ Res; 2001 Oct; 89(8):661-9. PubMed ID: 11597988
[TBL] [Abstract][Full Text] [Related]
35. Angiotensin-(1-7) stimulates cholesterol efflux from angiotensin II-treated cholesterol-loaded THP-1 macrophages through the suppression of p38 and c-Jun N-terminal kinase signaling.
Yang HY; Bian YF; Xiao CS; Liang B; Zhang N; Gao F; Yang ZM
Mol Med Rep; 2015 Jul; 12(1):1387-92. PubMed ID: 25779847
[TBL] [Abstract][Full Text] [Related]
36. Selective activation of CB2 receptor improves efferocytosis in cultured macrophages.
Jiang L; Chen Y; Huang X; Yuan A; Shao Q; Pu J; He B
Life Sci; 2016 Sep; 161():10-8. PubMed ID: 27474129
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of MERTK receptor tyrosine kinase in epithelial cancer cells drives efferocytosis in a gain-of-function capacity.
Nguyen KQ; Tsou WI; Calarese DA; Kimani SG; Singh S; Hsieh S; Liu Y; Lu B; Wu Y; Garforth SJ; Almo SC; Kotenko SV; Birge RB
J Biol Chem; 2014 Sep; 289(37):25737-49. PubMed ID: 25074939
[TBL] [Abstract][Full Text] [Related]
38. Defective Efferocytosis in a Murine Model of Sjögren's Syndrome Is Mediated by Dysfunctional Mer Tyrosine Kinase Receptor.
Witas R; Rasmussen A; Scofield RH; Radfar L; Stone DU; Grundahl K; Lewis D; Sivils KL; Lessard CJ; Farris AD; Nguyen CQ
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575873
[TBL] [Abstract][Full Text] [Related]
39. ODC (Ornithine Decarboxylase)-Dependent Putrescine Synthesis Maintains MerTK (MER Tyrosine-Protein Kinase) Expression to Drive Resolution.
Yurdagul A; Kong N; Gerlach BD; Wang X; Ampomah P; Kuriakose G; Tao W; Shi J; Tabas I
Arterioscler Thromb Vasc Biol; 2021 Mar; 41(3):e144-e159. PubMed ID: 33406854
[TBL] [Abstract][Full Text] [Related]
40. Angiotensin II stimulates the synthesis of vascular endothelial growth factor through the p38 mitogen activated protein kinase pathway in cultured mouse podocytes.
Kang YS; Park YG; Kim BK; Han SY; Jee YH; Han KH; Lee MH; Song HK; Cha DR; Kang SW; Han DS
J Mol Endocrinol; 2006 Apr; 36(2):377-88. PubMed ID: 16595708
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]